|
Patient | Indication | Age/ gender | Lens status | Follow-up (months) | TA in the 1st surgery | PVR | TA in retreatment | Baseline VA (Snellen) | Final VA (Snellen) | Baseline IOP (mmHg) | Final IOP (mmHg) | Biomicroscopy findings | Time of HSO removal (months) | Redetachment | Comments |
|
1 | RRD | 61/M | Pseudo | 22 | 1000 cts SO | CP6 | Oxane HD | 20/200 | 20/40 | 16 | 14 | Inflammatory cells in the AC, 1st month, KP in endothelium,6th month | 6 | No | Oil emulsification |
2 | RRD | 53/F | Pseudo | 18 | C3F8 gas | CP3 | Oxane HD | HM | HM | 15 | 15 | Normal | 36 | No | Ischemic optic nerve neuropathy; oil exchange due to IOP elevated; oil emulsification |
3 | RRD | 57/M | Phakic | 24 | C3F8 gas | CA3 | Oxane HD | HM | 20/200 | 12 | 12 | Inflammatory cells in the AC, 1st month | 11 | No | Ischemic optic nerve neuropathy; oil emulsification |
4 | RRD | 63/F | Phakic | 30 | 1000 cts SO | CP2 | Oxane HD | LP | HM | 10 | 13 | Oil in the AC, 6th month | 36 | No | Oil emulsification |
5 | RRD | 28/M | Phakic | 36 | C3F8 gas | CA6 | Oxane HD | 20/400 | 20/200 | 16 | 15 | KP in endothelium and cells in the AC, 1st month | 17 | No | IOL fixation |
6 | RRD | 22/F | Phakic | 42 | Oxane HD | CP1 | NA | 20/200 | 20/25 | 15 | 9 | Normal | 48 | No | RD secondary to Toxoplasmosis |
7 | RRD | 80/F | Phakic | 24 | 5000 cts SO | CP8 | Oxane HD | HM | CF 2m | 17 | 16 | KP in endothelium and cells in the AC, 1st month | NR | Yes | Giant tear; redetachment; oil emulsification |
8 | RRD | 66/M | Phakic | 24 | Oxane HD | CA3 | Oxane HD | HM | 20/63 | 10 | 12 | Normal | 8 | No | Epiretinal membrane; oil emulsification |
9 | RRD | 62/M | Phakic | 70 | 1000 cts SO | NA | Oxane HD | 20/400 | 20/100 | 14 | 12 | Normal | 72 | No | Oil exchange due to IOP elevated; oil emulsification |
10 | RRD | 41/M | Phakic | 6 | Oxane HD | CP3 | NA | CF 3m | 20/80 | 13 | 13 | Normal | NR | No | |
11 | RRD | 66/M | Pseudo | 12 | 5000 cts SO | CA10 | Oxane HD | 20/200 | 20/80 | 21 | 12 | Normal | NR | No | |
12 | RRD | 21/M | Phakic | 12 | Oxane HD | CA3 | NA | HM | 20/200 | 15 | 16 | Inflammatory cells in the AC, 1st month | NR | No | RD secondary to open ocular trauma |
13 | RRD | 62/M | Pseudo | 12 | Oxane HD | CP3 | Oxane HD | 20/200 | 20/80 | 14 | 17 | Inflammatory cells in the AC, 1st month | NR | No | Oil emulsification |
14 | RRD | 68/M | Pseudo | 6 | 1000 cts SO | CP2 | Oxane HD | CF 1m | 20/40 | 18 | 18 | Inflammatory cells in the AC, 1st month | NR | No | |
15 | RRD | 54/M | Phakic | 6 | 1000 cts SO | CP1 | Oxane HD | CF 3m | 20/32 | 24 | 17 | Inflammatory cells in the AC, 1st month | NR | No | |
16 | RRD | 20/F | Phakic | 8 | 1000 cts SO | CP3 | Oxane HD | LP | CF 1m | 22 | 14 | Normal | NR | No | Von Hippel-Lindau |
17 | RRD | 64/M | Phakic | 7 | 1000 cts SO | CP8 | Oxane HD | CF 1m | 20/80 | 23 | 13 | Inflammatory cells in the AC, 1st month | NR | No | Intraoperative bleeding in the first surgery |
18 | TRD | 56/M | Phakic | 20 | C3F8 gas | CP4 | Oxane HD | CF 1m | 20/80 | 13 | 20 | Normal | 6 | No | Oil emulsification |
19 | TRD | 24/M | Pseudo | 44 | C3F8 gas | NA | Oxane HD | HM | CF 3m | 14 | 14 | Normal | 46 | No | Optical nerve atrophy; oil emulsification |
20 | TRD | 49/M | Pseudo | 34 | Oxane HD | CA10 | 5000 cts SO | LP | HM | 14 | 15 | Normal | 6 | No | Oil exchange due to IOP elevated; oil emulsification |
21 | TRD | 63/F | Phakic | 13 | 1000 cts SO | CA10 | Oxane HD | LP | HM | 12 | 14 | Normal | NR | Yes | Ischemic optic nerve neuropathy and persistent retinal detachment |
22 | TRD | 29/M | Pseudo | 36 | Oxane HD | CA1 | NA | HM | 20/400 | 18 | 11 | Normal | NR | No | Oil emulsification |
23 | TRD | 17/M | Pseudo | 12 | 1000 cts SO | CA3 | Oxane HD | CF 1m | 20/80 | 17 | 10 | Oil emulsification, 6th month | NR | No | Oil emulsification |
24 | TRD | 39/M | Phakic | 12 | Oxane HD | CA10 | NA | LP | HM | 11 | 20 | Normal | NR | No | Ischemic optic nerve neuropathy |
25 | TRD | 60/M | Phakic | 6 | 1000 cts SO | CP3 | Oxane HD | CF 1m | 20/200 | 25 | 18 | Inflammatory cells in the AC, 1st month | NR | No | |
|